{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05157958",
      "OrgStudyIdInfo": {
        "OrgStudyId": "ALLO-ASC-DEB-201"
      },
      "Organization": {
        "OrgFullName": "Anterogen Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa",
      "OfficialTitle": "Double Blind, Randomized, Phase II Clinical Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET Versus Vehicle Control in Dystrophic Epidermolysis Bullosa (DEB) Patients"
    },
    "StatusModule": {
      "StatusVerifiedDate": "December 2021",
      "OverallStatus": "Not yet recruiting",
      "StartDateStruct": {
        "StartDate": "January 1, 2022",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "April 1, 2023",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "February 29, 2024",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 2, 2021",
      "StudyFirstSubmitQCDate": "December 2, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 15, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "December 2, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "December 15, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Anterogen Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "After confirming eligibility, a single subject with two selected target lesions will receive both ALLO-ASC-SHEET and Vehicle control, one target lesion for each IP (one target lesion for ALLO-ASC-SHEET and the other target for Vehicle control), and which lesion to apply which IP will be determined randomly at the time of enrollment using IWRS."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Dystrophic Epidermolysis Bullosa"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Double",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "6",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "ALLO-ASC-SHEET",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Allogeneic mesenchymal stem cells\n\nDressing for Dystrophic Epidermolysis Bullosa wound",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: ALLO-ASC-SHEET"
              ]
            }
          },
          {
            "ArmGroupLabel": "Conventional Therapy",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Hydrogel Sheet\n\nMatching control",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Vehicle Control"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "ALLO-ASC-SHEET",
            "InterventionDescription": "Weekly administration",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "ALLO-ASC-SHEET"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Vehicle Control",
            "InterventionDescription": "Weekly administration",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Conventional Therapy"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety of ALLO-ASC-SHEET versus matching control",
            "PrimaryOutcomeDescription": "Incidence, severity, relationship of adverse event",
            "PrimaryOutcomeTimeFrame": "First application to week 37"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Proportion of complete wound closure",
            "SecondaryOutcomeDescription": "Proportion of subject with target skin ulcer area meeting the definition of wound closure at 5 weeks after the completion of treatment period",
            "SecondaryOutcomeTimeFrame": "First application to week 17"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Key Inclusion Criteria:\n\nSubject diagnosed as dystrophic epidermolysis bullosa confirmed by clinical criteria and one of the following:\n\nImmunostaining test: patients who have reduced or no type 7 collagen in staining degree of immunofluorescence. Other antigens (laminin-332, type 17 collagen, plectin, integrin α6β4, type 5 and type 14 keratin, etc.) are normal in immune-staining.\nCOL7A1 mutational analysis: confirmation of COL7A1 genetic mutation.\n\nSubject with skin ulcer lesions of dystrophic epidermolysis bullosa meet the following criteria, on the screening start day (Visit 1) and treatment start day (enrollment day) (Visit 3):\n\nSubject has two skin ulcer lesions judged as comparable to compare the safety and efficacy by investigator during screening period and prior to the IP application (enrollment day).\nTwo skin ulcer lesions meeting criteria stated in 2a) should be sized 5-20 cm2 (inclusive)\nSubject who has two comparable target skin ulcer lesions, and each lesions with a change of size equal to or less than ±50% at treatment day (Visit 3) compared to that of screening day (Visit 1)\nSubject who has no clinical evidence of infection related signs/symptoms, or visible necrosis in the target skin ulcer area (area including ulcer lesion and surrounding area where the IP is to be applied).\n\nKey Exclusion Criteria:\n\nSubject who requires antibiotics due to bacterial infection on skin of the target skin ulcer area (area including ulcer lesion and surrounding area where the IP is to be applied).\nFemale subjects: pregnant woman (indicated by serum hCG test result at screening), breast-feeding patient, all sexually active patient, with child bearing potential in case of female*, who is not willing to contracept** during the clinical trial.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "4 Years",
      "MaximumAge": "60 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult"
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000004820",
            "ConditionMeshTerm": "Epidermolysis Bullosa"
          },
          {
            "ConditionMeshId": "D000016108",
            "ConditionMeshTerm": "Epidermolysis Bullosa Dystrophica"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012868",
            "ConditionAncestorTerm": "Skin Abnormalities"
          },
          {
            "ConditionAncestorId": "D000000013",
            "ConditionAncestorTerm": "Congenital Abnormalities"
          },
          {
            "ConditionAncestorId": "D000012873",
            "ConditionAncestorTerm": "Skin Diseases, Genetic"
          },
          {
            "ConditionAncestorId": "D000030342",
            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
          },
          {
            "ConditionAncestorId": "D000012871",
            "ConditionAncestorTerm": "Skin Diseases"
          },
          {
            "ConditionAncestorId": "D000012872",
            "ConditionAncestorTerm": "Skin Diseases, Vesiculobullous"
          },
          {
            "ConditionAncestorId": "D000003095",
            "ConditionAncestorTerm": "Collagen Diseases"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M7128",
            "ConditionBrowseLeafName": "Epidermolysis Bullosa",
            "ConditionBrowseLeafAsFound": "Epidermolysis Bullosa",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M17738",
            "ConditionBrowseLeafName": "Epidermolysis Bullosa Dystrophica",
            "ConditionBrowseLeafAsFound": "Dystrophic Epidermolysis Bullosa",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M12",
            "ConditionBrowseLeafName": "Congenital Abnormalities",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14824",
            "ConditionBrowseLeafName": "Skin Abnormalities",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14828",
            "ConditionBrowseLeafName": "Skin Diseases, Genetic",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14827",
            "ConditionBrowseLeafName": "Skin Diseases, Vesiculobullous",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T2098",
            "ConditionBrowseLeafName": "Epidermolysis Bullosa",
            "ConditionBrowseLeafAsFound": "Epidermolysis Bullosa",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T1991",
            "ConditionBrowseLeafName": "Dystrophic Epidermolysis Bullosa",
            "ConditionBrowseLeafAsFound": "Dystrophic Epidermolysis Bullosa",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}